Capital Markets: Equity (International Firms)
Greater China Region Guide 2024 : China
Band 1
Chambers Review
With an integrated team which is highly commended across the board and has a significant track record of work in Hong Kong, Skadden, Arps, Slate, Meagher & Flom & Affiliates is highly sought after for ECM expertise, and the team is frequently instructed on market-leading US and Hong Kong IPOs, as well as follow-on offerings. It is known for its excellent high-yield expertise and offers an accomplished investment-grade debt practice across a wide range of offerings, including project bonds, convertible notes and ADS issuances. It services clients in a wide range of industries including tech, fintech, healthcare, renewables, consumer goods and education. The firm's key clients include Nufarm, Hesai Group and Bilibili.
Work Highlights
- Skadden advised Li Auto on a USD2 billion at-the-market offering of American depositary shares.
- Skadden advised PT Medco Energi Internasional on its tender offers relating to USD650 million 7.375% senior notes due 2026 and USD650 million 6.375% senior notes due 2027.
Strengths
Provided by Chambers
"The Skadden team is very deep, with a large group of experienced and high-quality attorneys. The team are extremely responsive and they devote significant time and energy to understanding us and our needs; they are very good when it comes to advocating for our interests."
"Skadden show the depth and breadth of their team and we can always get quick responses. The insight they provided showed strong commercial awareness."
"The Skadden team is very deep, with a large group of experienced and high-quality attorneys. The team are extremely responsive and they devote significant time and energy to understanding us and our needs; they are very good when it comes to advocating for our interests."
"Skadden show the depth and breadth of their team and we can always get quick responses. The insight they provided showed strong commercial awareness."
Notable Practitioners
Li Haiping co-heads the firm's China practice and splits her time between the Hong Kong and Shanghai offices. She often advises Chinese TMT and biotech companies on IPOs and follow-on listings.
"She has all the best qualities I'd expect from an external counsel. Whenever we have any high-stakes matters, she's the first lawyer I would call. I trust her ability to come up with a solution that works best for us while also being mindful of other stakeholders' interests."
"She is wise, experienced, and her advice is always insightful and tailored to our business. It's an absolute delight working with her."
Paloma Wang wins acclaim for her expertise advising issuers and underwriters on biotech IPOs. She serves a host of clients from Skadden's base in Hong Kong.
"Paloma is extremely commercial and client-focused and is at the forefront of market-leading capital markets transactions."
"Paloma Wang is a great lawyer who is very approachable. I give her extra credit for her knowledge and experience in the biotech industry."
Jonathan Stone is head of Skadden's Hong Kong office and remains respected across a range of investment-grade DCM work, frequently acting for tech issuers on Reg S and convertible bond offerings.
"Jonathan is an extremely good technical lawyer."
"I'm very happy with the quality of advice. He's very knowledgeable and has in-depth experience and resources."
Wu Yuting is head of Skadden's Shanghai office and is focused on cross-border capital markets transactions, advising Chinese clients on US IPOs, as well as handling various Hong Kong homecoming listings.
"Yuting is a very experienced, diligent and smart lawyer. He knows our business and industry very well and can provide pertinent best practice and advice. He is always very responsive around the clock."
"Mr Wu can give pertinent and commercially meaningful legal advice on many legal issues. Even on some very cutting-edge issues that are less relevant to the law, he can also give some constructive suggestions."